Therapeutic Enzymes: Applications and Approaches to Pharmacological Improvement

被引:25
作者
Yari, Maryam [1 ]
Ghoshoon, Mohammad B. [2 ]
Vakili, Bahareh [1 ]
Ghasemi, Younes [1 ,2 ,3 ]
机构
[1] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Pharmaceut Sci Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Shiraz, Iran
关键词
Biopharmaceuticals; cancer; enzyme; fibrinolytic; protein engineering; replacement therapy; TISSUE-PLASMINOGEN ACTIVATOR; PANCREATIC EXOCRINE INSUFFICIENCY; ADENOSINE-DEAMINASE DEFICIENCY; SUCRASE-ISOMALTASE DEFICIENCY; PEGYLATED ARGININE DEIMINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; REPLACEMENT THERAPY; ESCHERICHIA-COLI; L-ASPARAGINASE; GENE-THERAPY;
D O I
10.2174/1389201018666170808150742
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Among therapeutic proteins, enzymes represent small and of course profitable market. They can be used to treat important, rare, and deadly diseases. Enzyme therapy is the only available treatment for certain disorders. Method: Here, pharmaceutical enzymes are reviewed. They are categorized in four main groups, enzymes in replacement therapy, enzymes in cancer treatment, enzymes for fibrinolysis, and finally enzymes that are used topically for various treatments. Furthermore, enzyme gene therapy and future perspective of therapeutic enzymes are mentioned in brief. Results: There are many important approved enzymes in pharmaceutical market. Several approaches such as point mutation, fusion protein designing, glycoengineering, and PEGylation were used to achieve improved enzymes. Although sometimes enzymes were engineered to facilitate production and purification process, appropriate delivery to target sites, extending half-life, and reducing immunogenicity are among the main goals of engineering approaches. Conclusion: Overall, enzymes play a critical role in treatment of common and rare diseases. Evaluation of new enzymes as well as improvement of approved enzymes are of the most important challenges in biotechnology.
引用
收藏
页码:531 / 540
页数:10
相关论文
共 106 条
[1]   In vitro comparisons between Carica papaya and pancreatic lipases during test meal lipolysis: Potential use of CPL in enzyme replacement therapy [J].
Abdelkafi, Slim ;
Fouquet, Benjamin ;
Barouh, Nathalie ;
Durner, Sophie ;
Pina, Michel ;
Scheirlinckx, Frantz ;
Villeneuvec, Pierre ;
Carriera, Frederic .
FOOD CHEMISTRY, 2009, 115 (02) :488-494
[2]   A survey of breakthrough therapy designations [J].
Aggarwal, Saurabh .
NATURE BIOTECHNOLOGY, 2014, 32 (04) :323-330
[3]   What's fueling the biotech engine-2012 to 2013 [J].
Aggarwal, Saurabh Rob .
NATURE BIOTECHNOLOGY, 2014, 32 (01) :32-39
[4]   Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency. [J].
Aiuti, Alessandro ;
Cattaneo, Federica ;
Galimberti, Stefania ;
Benninghoff, Ulrike ;
Cassani, Barbara ;
Callegaro, Luciano ;
Scaramuzza, Samantha ;
Andolfi, Grazia ;
Mirolo, Massimiliano ;
Brigida, Immacolata ;
Tabucchi, Antonella ;
Carlucci, Filippo ;
Eibl, Martha ;
Aker, Memet ;
Slavin, Shimon ;
Al-Mousa, Hamoud ;
Al Ghonaium, Abdulaziz ;
Ferster, Alina ;
Duppenthaler, Andrea ;
Notarangelo, Luigi ;
Wintergerst, Uwe ;
Buckley, Rebecca H. ;
Bregni, Marco ;
Marktel, Sarah ;
Valsecchi, Maria Grazia ;
Rossi, Paolo ;
Ciceri, Fabio ;
Miniero, Roberto ;
Bordignon, Claudio ;
Roncarolo, Maria-Grazia .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05) :447-458
[5]   Lysosomal storage disease: Gene therapy on both sides of the blood-brain [J].
Aronovich, Elena L. ;
Hackett, Perry B. .
MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) :83-93
[6]   Returning to the bench with adeno-associated virus 1 SERCA2a gene therapy [J].
Balsam, Leora B. ;
DeAnda, Abe, Jr. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (04) :1200-+
[7]   Streptokinase - a clinically useful thrombolytic agent [J].
Banerjee, A ;
Chisti, Y ;
Banerjee, UC .
BIOTECHNOLOGY ADVANCES, 2004, 22 (04) :287-307
[8]   Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease [J].
Ben Turkia, Hadhami ;
Gonzalez, Derlis E. ;
Barton, Norman W. ;
Zimran, Ari ;
Kabra, Madhulika ;
Lukina, Elena A. ;
Giraldo, Pilar ;
Kisinovsky, Isaac ;
Bavdekar, Ashish ;
Ben Dridi, Marie-Francoise ;
Gupta, Neerja ;
Kishnani, Priya S. ;
Sureshkumar, E. K. ;
Wang, Nan ;
Crombez, Eric ;
Bhirangi, Kiran ;
Mehta, Atul .
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (03) :179-184
[9]   Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier [J].
Boado, Ruben J. ;
Zhang, Yun ;
Zhang, Yufeng ;
Xia, Chun-fang ;
Wang, Yuntao ;
Pardridge, William M. .
BIOTECHNOLOGY AND BIOENGINEERING, 2008, 99 (02) :475-484
[10]   A recombinant human enzyme for enhanced interstitial transport of therapeutics [J].
Bookbinder, L. H. ;
Hofer, A. ;
Haller, M. F. ;
Zepeda, M. L. ;
G.-A., Keller ;
Lim, J. E. ;
Edgington, T. S. ;
Shepard, H. M. ;
Patton, J. S. ;
Frost, G. I. .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (02) :230-241